ŞEKEREL, B. E. Et Al. 2023. Efficacy, Safety, and Systemic Exposure of Once-Daily Indacaterol Acetate in Pediatric Asthma: A Randomized, Double-Blind, Controlled Dose-Finding Study. Clinical Drug Investigation , vol.43, no.9 , 719-728.

ŞEKEREL, B. E., Nell, H., Laki, I., Pak, T., Contreras, E., Kolarz, A., ... D’Andrea, P.(2023). Efficacy, Safety, and Systemic Exposure of Once-Daily Indacaterol Acetate in Pediatric Asthma: A Randomized, Double-Blind, Controlled Dose-Finding Study. Clinical Drug Investigation , vol.43, no.9, 719-728.

ŞEKEREL, BÜLENT Et Al. "Efficacy, Safety, and Systemic Exposure of Once-Daily Indacaterol Acetate in Pediatric Asthma: A Randomized, Double-Blind, Controlled Dose-Finding Study," Clinical Drug Investigation , vol.43, no.9, 719-728, 2023

ŞEKEREL, BÜLENT E. Et Al. "Efficacy, Safety, and Systemic Exposure of Once-Daily Indacaterol Acetate in Pediatric Asthma: A Randomized, Double-Blind, Controlled Dose-Finding Study." Clinical Drug Investigation , vol.43, no.9, pp.719-728, 2023

ŞEKEREL, B. E. Et Al. (2023) . "Efficacy, Safety, and Systemic Exposure of Once-Daily Indacaterol Acetate in Pediatric Asthma: A Randomized, Double-Blind, Controlled Dose-Finding Study." Clinical Drug Investigation , vol.43, no.9, pp.719-728.

@article{article, author={BÜLENT ENİS ŞEKEREL Et Al. }, title={Efficacy, Safety, and Systemic Exposure of Once-Daily Indacaterol Acetate in Pediatric Asthma: A Randomized, Double-Blind, Controlled Dose-Finding Study}, journal={Clinical Drug Investigation}, year=2023, pages={719-728} }